Cerebrovascular disease--advances in management

Area of Science:

• Neurology
• Emergency Medicine
• Clinical Trials

Background:

• Stroke management has advanced, necessitating its recognition as a medical emergency.
• Current recommendations focus on initial stroke management, particularly acute therapy for ischemic stroke.
• Evidence-based guidelines derived from clinical trials inform best practices.

Purpose of the Study:

• To summarize current recommendations for the initial management of major stroke types.
• To emphasize acute therapy strategies for ischemic stroke.
• To highlight the importance of accurate diagnosis and specialized care units.

Main Methods:

• Review of well-designed clinical trials on stroke diagnosis and treatment.
• Synthesis of recommendations for acute stroke care.
• Analysis of specific management strategies based on stroke type and mechanism.

Main Results:

• Establishment of acute stroke care teams and units in regional hospitals is recommended.
• Accurate diagnosis is crucial for effective stroke management.
• Intravenous thrombolysis (recombinant tissue plasminogen activator) or modified viper venom within 3 hours, or intra-arterial pro-urokinase within 6 hours, can improve outcomes for selected ischemic stroke patients.
• Neurosurgical intervention is indicated for certain ischemic or hemorrhagic strokes.

Conclusions:

• Prompt and accurate stroke diagnosis and management are critical.
• Specialized stroke units and multidisciplinary teams enhance patient care.
• Timely administration of acute therapies, such as thrombolysis, significantly impacts functional outcomes in ischemic stroke.
• Long-term management includes recurrence prevention and rehabilitation.